In the last 12 months, insiders at Medicus Pharma Ltd. ($MDCX) filed 42 transactions with the SEC: 0 open-market purchases totaling $0 and 1 sales totaling $578,940. Net insider sentiment: net selling.
Medicus Pharma Ltd. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- VELOCITY FUND PARTNERS, LP (TenPercentOwner) — 1 transaction totaling $578,940
- Quinlan James P. (Chief Financial Officer) — 5 transactions totaling $156,250
- Ashton William (Director) — 3 transactions totaling $0
- Ciaruffoli Robert J. (Director) — 3 transactions totaling $0
- Mehmud Faisal (Chief Medical Officer) — 3 transactions totaling $0
View all SEC Filings for Medicus Pharma Ltd. (MDCX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Smith Andrew Alasdair | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,029,144 | 9999.99% | 0.23% |
| March 30, 2026 | Ashton William | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | Bokhari Raza | Chief Executive Officer | A | Stock Option (right to buy) | 325000 | $0.00 | 325,000.0000 | 22,029,144 | 9999.99% | 1.48% |
| March 30, 2026 | Bonner Carolyn F. | President and CFO | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 22,029,144 | 9999.99% | 0.45% |
| March 30, 2026 | Brennan Edward J. | Chief Scientific Officer | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | Ciaruffoli Robert J. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | FISHMAN BARRY | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | Kaiser Larry | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | MAHAFFY PATRICK J | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | May Sara R. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | Mehmud Faisal | Chief Medical Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 22,029,144 | 9999.99% | 0.57% |
| March 30, 2026 | Raju Ajay | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| March 30, 2026 | Rodgers Cathy McMorris | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Bonner Carolyn F. | President and CFO | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 22,029,144 | 9999.99% | 0.34% |
| Dec. 16, 2025 | Smith Andrew Alasdair | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,029,144 | 9999.99% | 0.23% |
| Dec. 16, 2025 | Rodgers Cathy McMorris | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Raju Ajay | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Mehmud Faisal | Chief Medical Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 22,029,144 | 9999.99% | 0.34% |
| Dec. 16, 2025 | May Sara R. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | MAHAFFY PATRICK J | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Kaiser Larry | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | FISHMAN BARRY | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Ciaruffoli Robert J. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Dec. 16, 2025 | Brennan Edward J. | Chief Scientific Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,029,144 | 9999.99% | 0.23% |
| Dec. 16, 2025 | Bokhari Raza | Chief Executive Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 22,029,144 | 9999.99% | 0.57% |
| Dec. 16, 2025 | Ashton William | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 22,029,144 | 9999.99% | 0.11% |
| Aug. 13, 2025 | Quinlan James P. | Chief Financial Officer | M | Common Shares, no par value ("Common Shares") | 125000 | $0.81 | 254,147.0000 | 0 | 96.79% | 0.00% |
| Aug. 13, 2025 | Quinlan James P. | Chief Financial Officer | M | Stock Option (right to buy) | 125000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 13, 2025 | Quinlan James P. | Chief Financial Officer | M | Common Shares | 20000 | $2.75 | 274,147.0000 | 0 | 7.87% | 0.00% |
| Aug. 13, 2025 | Quinlan James P. | Chief Financial Officer | M | Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 22, 2025 | Bokhari Raza | Chief Executive Officer | A | Stock Option (right to buy) | 250000 | $0.00 | 300,000.0000 | 0 | 500.00% | 0.00% |
| July 22, 2025 | Ashton William | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 40,000.0000 | 0 | 166.67% | 0.00% |
| July 22, 2025 | Bonner Carolyn F. | President | A | Stock Option (right to buy) | 50000 | $0.00 | 60,000.0000 | 0 | 500.00% | 0.00% |
| July 22, 2025 | Brennan Edward J. | Chief Scientific Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 70,000.0000 | 0 | 250.00% | 0.00% |
| July 22, 2025 | Ciaruffoli Robert J. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 40,000.0000 | 0 | 166.67% | 0.00% |
| July 22, 2025 | FISHMAN BARRY | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 40,000.0000 | 0 | 166.67% | 0.00% |
| July 22, 2025 | Kaiser Larry | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 40,000.0000 | 0 | 166.67% | 0.00% |
| July 22, 2025 | May Sara R. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 40,000.0000 | 0 | 166.67% | 0.00% |
| July 22, 2025 | Mehmud Faisal | Chief Medical Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 150,000.0000 | 0 | 50.00% | 0.00% |
| July 22, 2025 | Quinlan James P. | Chief Financial Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 70,000.0000 | 0 | 250.00% | 0.00% |
| July 22, 2025 | Raju Ajay | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2025 | VELOCITY FUND PARTNERS, LP | TenPercentOwner | S | Medicus Pharma LTD | 75000 | $7.72 | 3,248,741.0000 | 0 | 2.26% | 0.00% |